Objectives
After participating in this educational activity, attendees should be able to:
1|Provide overview of the impact on induction agent choice and invasive hemodynamic monitoring on all-cause mortality
2|Describe recent advances in the use of biomarkers for lung cancer screening
3|List benefits and limitations of cryobiopsy compared to forceps biopsy in the diagnosis of interstitial lung disease
Presenter(s):
Carolyn G Garcia, MD, MS
Chief | Division of Pulmonary and Critical Care
Co-Medical Director, Pulmonary Rehabilitation Services, Baystate Medical Center
Assistant Professor | Departments of Medicine and Healthcare Delivery and Population Sciences
UMass Chan School of Medicine - Baystate
Puncho Gurung, MD
Associate Program Director, Pulmonary and Critical Care Fellowship
Division of Pulmonary and Critical Care Medicine
Eduardo R. Núñez, MD, MS
Pulmonary and Critical Care Medicine
Baystate Medical Center
Assistant Professor
Departments of Medicine and Healthcare Delivery and Population Sciences
Medical Director Lung Cancer Screening Program
| Name | Role | Financial Relationship Disclosures | Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation? |
|---|---|---|---|
| Carolyn Garcia,MD | Speaker | No relevant relationships with ineligible companies to disclose | No |
| Puncho Gurung MD | Speaker | No relevant relationships with ineligible companies to disclose | No |
| Eduardo R. Núñez, MD, MS | Speaker | No relevant relationships with ineligible companies to disclose | No |
- 1.00 AAPA Category 1 CME creditBaystate Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PA’s should only claim credit commensurate with the extent of their participation.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 BCIPE Instructional Hours
Facebook
X
LinkedIn
Forward